| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PLP(R) | 388 | 73.3% | -3.96 | 25 | 24.5% |
| LAL(R) | 56 | 10.6% | -0.52 | 39 | 38.2% |
| LH(R) | 54 | 10.2% | -2.75 | 8 | 7.8% |
| CRE(R) | 23 | 4.3% | -0.06 | 22 | 21.6% |
| CentralBrain-unspecified | 7 | 1.3% | 0.19 | 8 | 7.8% |
| Optic-unspecified(R) | 1 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns PLP042a | % In | CV |
|---|---|---|---|---|---|
| M_l2PNm16 (R) | 2 | ACh | 71 | 14.0% | 0.1 |
| CB3013 (R) | 2 | unc | 44 | 8.7% | 0.3 |
| PLP232 (R) | 1 | ACh | 40 | 7.9% | 0.0 |
| WED045 (R) | 1 | ACh | 28 | 5.5% | 0.0 |
| CB2922 (R) | 1 | GABA | 14 | 2.8% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 13 | 2.6% | 0.0 |
| CB2151 (R) | 2 | GABA | 13 | 2.6% | 0.7 |
| WEDPN6A (R) | 4 | GABA | 13 | 2.6% | 0.3 |
| WEDPN5 (R) | 1 | GABA | 12 | 2.4% | 0.0 |
| CB4114 (R) | 3 | Glu | 10 | 2.0% | 0.6 |
| SMP151 (L) | 2 | GABA | 9 | 1.8% | 0.8 |
| LAL189 (L) | 2 | ACh | 9 | 1.8% | 0.3 |
| mALB4 (L) | 1 | GABA | 8 | 1.6% | 0.0 |
| WEDPN17_a2 (R) | 2 | ACh | 8 | 1.6% | 0.2 |
| LAL055 (R) | 1 | ACh | 7 | 1.4% | 0.0 |
| M_l2PN10t19 (R) | 1 | ACh | 7 | 1.4% | 0.0 |
| WEDPN4 (R) | 1 | GABA | 7 | 1.4% | 0.0 |
| VL2a_adPN (R) | 1 | ACh | 7 | 1.4% | 0.0 |
| CB2494 (R) | 1 | ACh | 6 | 1.2% | 0.0 |
| WEDPN16_d (R) | 1 | ACh | 6 | 1.2% | 0.0 |
| LAL071 (R) | 3 | GABA | 6 | 1.2% | 0.4 |
| CB1202 (R) | 1 | ACh | 5 | 1.0% | 0.0 |
| LT72 (R) | 1 | ACh | 5 | 1.0% | 0.0 |
| WED121 (R) | 1 | GABA | 5 | 1.0% | 0.0 |
| mALB2 (L) | 1 | GABA | 5 | 1.0% | 0.0 |
| LHPV6q1 (R) | 1 | unc | 5 | 1.0% | 0.0 |
| WEDPN17_a1 (R) | 2 | ACh | 5 | 1.0% | 0.6 |
| CB3759 (R) | 2 | Glu | 5 | 1.0% | 0.6 |
| LoVP13 (R) | 2 | Glu | 5 | 1.0% | 0.2 |
| SMP151 (R) | 2 | GABA | 5 | 1.0% | 0.2 |
| LHCENT3 (R) | 1 | GABA | 4 | 0.8% | 0.0 |
| M_lvPNm47 (R) | 1 | ACh | 4 | 0.8% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 4 | 0.8% | 0.0 |
| mALB1 (L) | 1 | GABA | 4 | 0.8% | 0.0 |
| SMP007 (L) | 2 | ACh | 4 | 0.8% | 0.5 |
| WEDPN17_c (R) | 2 | ACh | 4 | 0.8% | 0.0 |
| WEDPN8B (R) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHPV4g1 (R) | 1 | Glu | 3 | 0.6% | 0.0 |
| LHPV2a1_c (R) | 1 | GABA | 3 | 0.6% | 0.0 |
| CB1599 (R) | 1 | ACh | 3 | 0.6% | 0.0 |
| CB1705 (R) | 2 | GABA | 3 | 0.6% | 0.3 |
| PLP044 (R) | 2 | Glu | 3 | 0.6% | 0.3 |
| CRE052 (R) | 2 | GABA | 3 | 0.6% | 0.3 |
| CB1504 (R) | 2 | Glu | 3 | 0.6% | 0.3 |
| LHPV6h2 (R) | 2 | ACh | 3 | 0.6% | 0.3 |
| WED093 (R) | 2 | ACh | 3 | 0.6% | 0.3 |
| PPM1202 (R) | 2 | DA | 3 | 0.6% | 0.3 |
| LHPV2a1_d (R) | 2 | GABA | 3 | 0.6% | 0.3 |
| LoVP50 (R) | 2 | ACh | 3 | 0.6% | 0.3 |
| OA-VUMa6 (M) | 2 | OA | 3 | 0.6% | 0.3 |
| PLP041 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| CRE095 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| AOTU034 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| PLP036 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| WEDPN10B (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| CL234 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| WEDPN11 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| WED181 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| VL2p_adPN (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| PLP042_a (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| PLP043 (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| CB4112 (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| WED081 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| SMP008 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PFL1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP142 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| M_imPNl92 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3895 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV2c4 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| SIP042_a (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB1149 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP039 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB3010 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LC20b (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| WEDPN17_b (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1213 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| WEDPN7A (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP171 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| WEDPN7C (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| WED034 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHAV1a4 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV2b11 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CRE051 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV2i2_b (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV4a2 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| WEDPN10A (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHCENT5 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| WEDPN9 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| LAL183 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV10b1 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| mALD1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns PLP042a | % Out | CV |
|---|---|---|---|---|---|
| CB1504 (R) | 3 | Glu | 31 | 11.8% | 0.4 |
| CRE052 (R) | 5 | GABA | 19 | 7.2% | 0.4 |
| LHPV2a1_e (R) | 1 | GABA | 15 | 5.7% | 0.0 |
| LHPV2a1_d (R) | 3 | GABA | 15 | 5.7% | 0.6 |
| WED020_b (R) | 2 | ACh | 15 | 5.7% | 0.1 |
| PLP044 (R) | 3 | Glu | 14 | 5.3% | 0.6 |
| FB2D (R) | 3 | Glu | 13 | 4.9% | 0.6 |
| PLP209 (R) | 1 | ACh | 9 | 3.4% | 0.0 |
| CB2873 (R) | 3 | Glu | 8 | 3.0% | 0.4 |
| LHPV2a1_c (R) | 3 | GABA | 8 | 3.0% | 0.5 |
| LAL156_a (R) | 1 | ACh | 7 | 2.7% | 0.0 |
| CB1202 (R) | 1 | ACh | 7 | 2.7% | 0.0 |
| LAL138 (R) | 1 | GABA | 7 | 2.7% | 0.0 |
| LAL142 (R) | 1 | GABA | 6 | 2.3% | 0.0 |
| PLP257 (R) | 1 | GABA | 4 | 1.5% | 0.0 |
| LAL156_b (R) | 1 | ACh | 4 | 1.5% | 0.0 |
| SMP177 (R) | 1 | ACh | 4 | 1.5% | 0.0 |
| CB2733 (R) | 1 | Glu | 3 | 1.1% | 0.0 |
| ER3a_c (R) | 1 | GABA | 3 | 1.1% | 0.0 |
| ER1_a (R) | 1 | GABA | 3 | 1.1% | 0.0 |
| LAL131 (R) | 1 | Glu | 3 | 1.1% | 0.0 |
| PLP036 (R) | 1 | Glu | 3 | 1.1% | 0.0 |
| LHCENT14 (R) | 1 | Glu | 3 | 1.1% | 0.0 |
| LHPV6o1 (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| SMP489 (R) | 2 | ACh | 3 | 1.1% | 0.3 |
| CB2881 (R) | 1 | Glu | 2 | 0.8% | 0.0 |
| LAL132_b (R) | 1 | Glu | 2 | 0.8% | 0.0 |
| CB2713 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| WEDPN1A (R) | 1 | GABA | 2 | 0.8% | 0.0 |
| SIP022 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| SMP568_b (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| LHAV2b5 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| AVLP015 (R) | 1 | Glu | 2 | 0.8% | 0.0 |
| PLP046 (R) | 2 | Glu | 2 | 0.8% | 0.0 |
| MBON10 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| WED097 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.4% | 0.0 |
| CRE026 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP007 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP371_a (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB2245 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| WED145 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| PLP042_b (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| MB-C1 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| WEDPN7A (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CL091 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LAL048 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| PLP026 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV2e1_a (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| CB1976 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| WED155 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB4183 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV1a4 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| FB5C (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| FB2B_a (R) | 1 | unc | 1 | 0.4% | 0.0 |
| SMP371_b (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CRE051 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| CRE066 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV3e2 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| WEDPN3 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| LAL064 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP293 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CRE088 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| FB2A (R) | 1 | DA | 1 | 0.4% | 0.0 |
| ATL012 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LAL055 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| WEDPN12 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| PLP208 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| PPL201 (R) | 1 | DA | 1 | 0.4% | 0.0 |
